A new benchmark has been launched by the Access to Medicine Foundation comparing pharmaceutical companies in their action to tackle growing antimicrobial resistance
Browsing: Clinical > Antimicrobial Resistance
Want to find out what’s been happening this year? Editor, Martha Powell, highlights the best of 2017’s infectious diseases research in an A–Z.
Researchers have demonstrated that antibiotic-resistance plasmids persist in the absence of antibiotics, provided that the efficiency of plasmid transfer exceeds a critical threshold, highlighting the limitations of ‘resistance-reversal’ strategies.
In this article, carbapenem antimicrobial susceptibility testing profiles were determined in a population of Klebsiella pneumoniae, and their resistance assessed based on previous and current Clinical and Laboratory Standards Institute criteria.
Continuing our focus on antimicrobial resistance, Editor, Martha Powell, takes a closer look at the steps that can be taken to prevent the spread of drug resistance.
Researchers have unveiled novel pathways controlled by the multiple antibiotic resistance operon and identified new ways in which bacteria protect themselves against antibiotics.
As part of our focus around World Antibiotic Awareness Week (13–19 November) we spoke to Professor Jonathan Cooke, a pharmacologist and pharmacist based in the UK who holds a special interest in antimicrobial resistance. He shares his thoughts on this pressing issue below: